CD274 and breast cancer: Indeed, many cells within the TME can impair the response to ICIs by inhibiting effector T cells (172), and depletion of intra-tumor MDSCs or Treg cells improved responsiveness to PD-1/PD-L1 blockade in preclinical models of BC (173, 174).